NEUROFIBROMATOSIS TYPE 2
Clinical trials for NEUROFIBROMATOSIS TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS TYPE 2 trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare nerve tumor disorder: Multi-Drug trial launches
Disease control Recruiting nowThis study tests several experimental drugs in people with NF2-related schwannomatosis, a genetic condition that causes non-cancerous tumors on nerves. The goal is to see if these drugs can shrink tumors and control the disease. About 109 participants will receive one of three dr…
Matched conditions: NEUROFIBROMATOSIS TYPE 2
Phase: PHASE2 • Sponsor: Scott R. Plotkin, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
NF2 patients wanted for Decade-Long observation study
Knowledge-focused Recruiting nowThis study follows 269 people with neurofibromatosis type 2 (NF2) for up to 10 years to learn how the disease progresses. Participants will have yearly exams, MRI scans, hearing tests, and blood draws. The goal is to understand tumor growth, hearing loss, and speech or swallowing…
Matched conditions: NEUROFIBROMATOSIS TYPE 2
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC